S&P 500 7,474.88 +0.42% NASDAQ 25,704.42 +0.77% DOW 51,962.58 +0.24% R2K 2,961.77 +0.66% VIX 17.65 -5.36% US 10Y 4.62 +0.52% DXY 101.12 +0.13% GOLD 4,056.30 +1.15% CRUDE 84.59 +1.63% BITCOIN 66,602.89 +2.10%

S&P 500 7,474.88 +0.42% NASDAQ 25,704.42 +0.77% DOW 51,962.58 +0.24% R2K 2,961.77 +0.66% VIX 17.65 -5.36% US 10Y 4.62 +0.52% DXY 101.12 +0.13% GOLD 4,056.30 +1.15% CRUDE 84.59 +1.63% BITCOIN 66,602.89 +2.10%

Next Bullish Trade

Sign in

Account

Create free accountFree dashboard, no payment Sign inEmail yourself a login link CoursesYour library & catalog

CORT

Corcept Therapeutics Incorporated NCM · CORT

$93.89 +2.32 (+2.53%)

Extended · +1.60σ

+ Compare Open in Sniper

News · CORT

Full news feed →

Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook

The Motley Fool · 8d ago

State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?

The Motley Fool · 46d ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines – CORT

GlobeNewswire Inc. · 90d ago

Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. · 90d ago

CORCEPT DEADLINE TOMORROW: Bragar Eagel & Squire, P.C. Urges Corcept Therapeutics Incorporated Investors to Contact the Firm Regarding Their Rights Before April 21st

GlobeNewswire Inc. · 91d ago

CORT 3-DAY DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure

GlobeNewswire Inc. · 93d ago

CORT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT

GlobeNewswire Inc. · 94d ago

CORT Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Corcept Therapeutics Incorporated Securities Class Action Lawsuit — The Gross Law Firm

GlobeNewswire Inc. · 95d ago

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated and Encourages Investors to Contact the Firm

GlobeNewswire Inc. · 98d ago

Corcept Therapeutics Incorporated Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – CORT

GlobeNewswire Inc. · 98d ago

INVESTOR DEADLINE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Corcept Class Action Lawsuit– Hagens Berman

GlobeNewswire Inc. · 101d ago

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Corcept Therapeutics Incorporated (CORT), Lakeland Industries, Inc. (LAKE), and Navan, Inc. (NAVN) Announced by Holzer & Holzer, LLC

GlobeNewswire Inc. · 103d ago

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. · 109d ago

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GlobeNewswire Inc. · 111d ago

CORT INVESTOR UPDATE: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss

GlobeNewswire Inc. · 111d ago

Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week

The Motley Fool · 115d ago

Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. · 116d ago

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

GlobeNewswire Inc. · 117d ago